Related Experiment Videos

Continuation of proton pump inhibitors from hospital to community

Kenneth Grant1, Noor Al-Adhami, June Tordoff

  • 1Pharmacy Department, Dunedin Hospital, Dunedin, New Zealand.

Pharmacy World & Science : PWS
|October 27, 2006
PubMed

Insights

Many patients inappropriately start proton pump inhibitor (PPI) treatment, with poor discharge information leading to continued use. Improved clinical indication and communication are needed for effective PPI management.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pharmacology

Background:

  • Proton pump inhibitors (PPIs) are widely used medications.
  • Assessing the appropriate initiation and continuation of PPI therapy is crucial for patient care.
  • Hospital discharge practices can significantly impact long-term medication management.

Purpose of the Study:

  • To evaluate the appropriateness of initiating proton pump inhibitor (PPI) treatment during hospitalization.
  • To assess the quality of discharge information provided to patients and general practitioners (GPs).
  • To determine the association between hospital initiation and continued PPI treatment in the community.

Main Methods:

  • A survey was conducted on inpatients newly initiated on a PPI between June and August 2003.
  • The appropriateness of PPI therapy initiation was assessed.
  • Discharge information completeness and PPI continuation at 6 months post-discharge were evaluated.

Main Results:

  • 60% of patients were appropriately initiated on PPI treatment.
  • Less than 25% of discharge summaries included recommendations for PPI treatment duration or review.
  • Appropriateness of initiation did not significantly influence long-term treatment duration, with many patients continuing PPIs regardless of initial indication.

Conclusions:

  • Proton pump inhibitors (PPIs) should be initiated only when clinically indicated.
  • Discharge information, particularly regarding PPI treatment duration and dose titration, needs enhancement for better continuity of care.
  • Improved communication between hospital and community care providers is essential for optimizing PPI use.
Abstract

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Restorative Care01:19

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...